'Left ventricular ejection fraction' diaporamas de présentation

OVERVIEW OF TREATMENT OF CONGESTIVE HEART FAILURE

OVERVIEW OF TREATMENT OF CONGESTIVE HEART FAILURE. OVERVIEW . Background and Historical Perspective Determinants of Cardiac Output and Hemodynamic Intervention Newer Therapeutics . EVOLUTION IN CONCEPTS. Cardio-renal (pre 1970) : Digoxin, diuretics

693 views • 43 slides

Cardiac Toxicity on NSABP B-31

Cardiac Toxicity on NSABP B-31. Charles E. Geyer, Jr. MD Director of Medical Affairs NSABP Pittsburgh, PA September 17, 2005. B-31 Cardiac Monitoring Program Development Group. John Bryant, PhD Edward Romond, MD Elizabeth Tan-Chiu, MD Sandra Swain, MD .

518 views • 17 slides

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. www.shift-study.com.

284 views • 12 slides

272 views • 12 slides